Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury

T. Ueno, Y. Ohori, J. Ito, S. Hoshikawa, Shinichirou Yamamoto, K. Nakamura, S. Tanaka, M. Akai, Y. Tobimatsu, T. Ogata

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Study design:An in vivo study in a rat model of acute spinal cord contusion.Objectives:To assess the efficacy of novel therapies for acute spinal cord injury (SCI), methods to evaluate accurately the effects of these therapies should be developed. Although neurological examination is commonly used for this purpose, unstable clinical conditions and the spontaneous recovery of neurological function in the acute and subacute phases after injury make this measurement unreliable. Recent studies have reported that the phosphorylated form of the high-molecular-weight neurofilament subunit NF-H (pNF-H), a new biomarker for axonal degeneration, can be measured in serum samples in experimental SCI animals. Therefore, we aimed to investigate the use of plasma pNF-H as an indicator of the efficacy of minocycline, a neuroprotective drug, for treating SCI.Setting:This study was carried out at Saitama, Japan.Methods:Spinal cord injured rats received either minocycline or saline intraperitoneally. The plasma pNF-H levels and functional hind limb score were determined after the injury.Results:Minocycline treatment reduced plasma pNF-H levels at 3 and 4 days post-injury (dpi). Rats with lower plasma pNF-H levels at 3 dpi had higher hind limb motor score at 28 dpi.Conclusions:pNF-H levels may serve as a biomarker for evaluating the efficacy of therapies for SCI.

Original languageEnglish
Pages (from-to)333-336
Number of pages4
JournalSpinal Cord
Volume49
Issue number3
DOIs
Publication statusPublished - 2011 Mar
Externally publishedYes

Keywords

  • biomarker
  • minocycline
  • pNF-H
  • spinal cord injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury. / Ueno, T.; Ohori, Y.; Ito, J.; Hoshikawa, S.; Yamamoto, Shinichirou; Nakamura, K.; Tanaka, S.; Akai, M.; Tobimatsu, Y.; Ogata, T.

In: Spinal Cord, Vol. 49, No. 3, 03.2011, p. 333-336.

Research output: Contribution to journalArticle

Ueno, T, Ohori, Y, Ito, J, Hoshikawa, S, Yamamoto, S, Nakamura, K, Tanaka, S, Akai, M, Tobimatsu, Y & Ogata, T 2011, 'Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury', Spinal Cord, vol. 49, no. 3, pp. 333-336. https://doi.org/10.1038/sc.2010.116
Ueno, T. ; Ohori, Y. ; Ito, J. ; Hoshikawa, S. ; Yamamoto, Shinichirou ; Nakamura, K. ; Tanaka, S. ; Akai, M. ; Tobimatsu, Y. ; Ogata, T. / Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury. In: Spinal Cord. 2011 ; Vol. 49, No. 3. pp. 333-336.
@article{0ff2ecf56c6c4d1bb9b1783d20f6b8a5,
title = "Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury",
abstract = "Study design:An in vivo study in a rat model of acute spinal cord contusion.Objectives:To assess the efficacy of novel therapies for acute spinal cord injury (SCI), methods to evaluate accurately the effects of these therapies should be developed. Although neurological examination is commonly used for this purpose, unstable clinical conditions and the spontaneous recovery of neurological function in the acute and subacute phases after injury make this measurement unreliable. Recent studies have reported that the phosphorylated form of the high-molecular-weight neurofilament subunit NF-H (pNF-H), a new biomarker for axonal degeneration, can be measured in serum samples in experimental SCI animals. Therefore, we aimed to investigate the use of plasma pNF-H as an indicator of the efficacy of minocycline, a neuroprotective drug, for treating SCI.Setting:This study was carried out at Saitama, Japan.Methods:Spinal cord injured rats received either minocycline or saline intraperitoneally. The plasma pNF-H levels and functional hind limb score were determined after the injury.Results:Minocycline treatment reduced plasma pNF-H levels at 3 and 4 days post-injury (dpi). Rats with lower plasma pNF-H levels at 3 dpi had higher hind limb motor score at 28 dpi.Conclusions:pNF-H levels may serve as a biomarker for evaluating the efficacy of therapies for SCI.",
keywords = "biomarker, minocycline, pNF-H, spinal cord injury",
author = "T. Ueno and Y. Ohori and J. Ito and S. Hoshikawa and Shinichirou Yamamoto and K. Nakamura and S. Tanaka and M. Akai and Y. Tobimatsu and T. Ogata",
year = "2011",
month = "3",
doi = "10.1038/sc.2010.116",
language = "English",
volume = "49",
pages = "333--336",
journal = "Spinal Cord",
issn = "1362-4393",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Hyperphosphorylated neurofilament NF-H as a biomarker of the efficacy of minocycline therapy for spinal cord injury

AU - Ueno, T.

AU - Ohori, Y.

AU - Ito, J.

AU - Hoshikawa, S.

AU - Yamamoto, Shinichirou

AU - Nakamura, K.

AU - Tanaka, S.

AU - Akai, M.

AU - Tobimatsu, Y.

AU - Ogata, T.

PY - 2011/3

Y1 - 2011/3

N2 - Study design:An in vivo study in a rat model of acute spinal cord contusion.Objectives:To assess the efficacy of novel therapies for acute spinal cord injury (SCI), methods to evaluate accurately the effects of these therapies should be developed. Although neurological examination is commonly used for this purpose, unstable clinical conditions and the spontaneous recovery of neurological function in the acute and subacute phases after injury make this measurement unreliable. Recent studies have reported that the phosphorylated form of the high-molecular-weight neurofilament subunit NF-H (pNF-H), a new biomarker for axonal degeneration, can be measured in serum samples in experimental SCI animals. Therefore, we aimed to investigate the use of plasma pNF-H as an indicator of the efficacy of minocycline, a neuroprotective drug, for treating SCI.Setting:This study was carried out at Saitama, Japan.Methods:Spinal cord injured rats received either minocycline or saline intraperitoneally. The plasma pNF-H levels and functional hind limb score were determined after the injury.Results:Minocycline treatment reduced plasma pNF-H levels at 3 and 4 days post-injury (dpi). Rats with lower plasma pNF-H levels at 3 dpi had higher hind limb motor score at 28 dpi.Conclusions:pNF-H levels may serve as a biomarker for evaluating the efficacy of therapies for SCI.

AB - Study design:An in vivo study in a rat model of acute spinal cord contusion.Objectives:To assess the efficacy of novel therapies for acute spinal cord injury (SCI), methods to evaluate accurately the effects of these therapies should be developed. Although neurological examination is commonly used for this purpose, unstable clinical conditions and the spontaneous recovery of neurological function in the acute and subacute phases after injury make this measurement unreliable. Recent studies have reported that the phosphorylated form of the high-molecular-weight neurofilament subunit NF-H (pNF-H), a new biomarker for axonal degeneration, can be measured in serum samples in experimental SCI animals. Therefore, we aimed to investigate the use of plasma pNF-H as an indicator of the efficacy of minocycline, a neuroprotective drug, for treating SCI.Setting:This study was carried out at Saitama, Japan.Methods:Spinal cord injured rats received either minocycline or saline intraperitoneally. The plasma pNF-H levels and functional hind limb score were determined after the injury.Results:Minocycline treatment reduced plasma pNF-H levels at 3 and 4 days post-injury (dpi). Rats with lower plasma pNF-H levels at 3 dpi had higher hind limb motor score at 28 dpi.Conclusions:pNF-H levels may serve as a biomarker for evaluating the efficacy of therapies for SCI.

KW - biomarker

KW - minocycline

KW - pNF-H

KW - spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=79952441779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952441779&partnerID=8YFLogxK

U2 - 10.1038/sc.2010.116

DO - 10.1038/sc.2010.116

M3 - Article

C2 - 20805831

AN - SCOPUS:79952441779

VL - 49

SP - 333

EP - 336

JO - Spinal Cord

JF - Spinal Cord

SN - 1362-4393

IS - 3

ER -